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Abstract 19 
An increasing number of veterinarians use flow cytometry (FC) for immunophenotyping and 20 
staging of canine lymphoma, since it is minimally invasive and cost effective. The aim of this 21 
retrospective study was to assess pre-analytical variables that might influence the diagnostic utility 22 
of FC of lymph node (LN) fine needle aspirate (FNA) specimens from dogs with 23 
lymphoproliferative diseases. The database of the Department of Veterinary Medicine, University 24 
of Milan, Italy, from 2009 to 2015 was interrogated. Cases were selected if a LN FNA sample was 25 
sent for immunophenotyping and if the final FC report was available. Cases were grouped into 26 
‘diagnostic’ and ‘non-diagnostic’. The following pre-analytical factors were analysed by univariate 27 
and multivariate analysis: patient-related factors (breed, age, sex, size), operator-related factors 28 
including sampling and shipping (year, season, shipping method, submitting veterinarian), and 29 
sample-related factors (type of sample material, cellular concentration, cytological smears, 30 
artefacts). 31 
 32 
 A total of 987 cases fulfilled the inclusion criteria. Among all evaluated variables, the 33 
submitting veterinarian, sample material, sample cellularity and artefacts affected the likelihood of 34 
having a diagnostic sample. The availability of specimens from different sites and of cytological 35 
smears increased the odds of obtaining a diagnostic result. Major artefacts affecting diagnostic 36 
utility included poor cellularity and the presence of dead cells. Flow cytometry on LN FNA samples 37 
yielded conclusive results in more than 90% of cases with adequate sample quality and sampling 38 
conditions. 39 
 40 
Keywords: Canine lymphoma; Diagnosis; Fine needle aspirate; Flow cytometry; Pre-analytical  41 
Introduction 42 
Lymphoma is the most common haematopoietic malignancy in dogs, with an incidence of 43 
about 84 cases/100,000 dogs per year (Dorn et al., 1970). Classification schemes, and diagnostic 44 
and therapeutic approaches tend to reproduce those applied in human medicine, with only a few 45 
exceptions, including a higher prevalence of multicentric lymphomas and diffuse versus nodular 46 
lymphoma (Marconato et al., 2013a ). These features favour the use of minimally invasive 47 
diagnostic techniques such as fine needle aspirate (FNA) cytology and subsequent flow cytometry 48 
(FC) (Comazzi and Gelain, 2011). 49 
 50 
Fine-needle aspiration and cytology is now considered to be the first diagnostic approach for 51 
canine lymphoma (Marconato et al., 2013a), since it is cost-effective, minimally invasive and well 52 
accepted by the owners. The information provided by cytology in association with other ancillary 53 
techniques sets the basis for therapeutic decisions in the majority of cases, as reported by a recent 54 
survey (Regan et al., 2013). Recently, the use of FC has significantly increased in veterinary 55 
medicine due to the increased number of canine-specific monoclonal antibodies available. Flow 56 
cytometry is routinely used for immunophenotyping of lymphoma and to refine the diagnosis of 57 
specific lymphoma subtypes (Seelig et al., 2014; Martini et al., 2015). It can also be used for 58 
lymphoma staging (Marconato et al., 2013b) and to evaluate minimal residual disease after 59 
treatment (Aresu et al., 2014). However, veterinary FC facilities are currently limited to a few 60 
reference laboratories, mainly due to economic reasons. Most of them are part of academic 61 
institutions and provide services for veterinary hospitals, veterinary laboratories and private 62 
practices. The specific requirements for sample preparation and shipping may partially limit the 63 
utility when FC is not readily available and could also bias results, even though specific studies are 64 
still lacking. 65 
 66 
Since 2008, the FC facility of the authors’ institutions offer a reference service for canine 67 
lymphoma and leukaemia flow cytometry, receiving samples from veterinary oncologists working 68 
in the same institution and external veterinarians from Italy, Switzerland, Portugal, Spain, Slovenia 69 
and the UK. Given our experience, we hypothesised that different sampling techniques, shipping 70 
and storage conditions might bias the results and influence the diagnostic performance of FC. To 71 
the authors’ knowledge, only one study on the influence of pre-analytical variables on diagnostic 72 
performance of FC is available in cats (Martini et al., 2017), but a study evaluating the effects of 73 
such variables in a high number of dogs is still lacking. 74 
 75 
The aim of this retrospective study was to assess whether and how pre-analytical variables 76 
might influence the diagnostic utility of lymph node (LN) FNA samples obtained from dogs with 77 
clinically suspected lymphoproliferative disease analysed by FC. The goal was to create 78 
recommendations for sampling techniques, sample storage and shipping in order to decrease pre-79 
analytical errors and to increase the diagnostic utility of FC for the diagnosis of lymphoma and 80 
leukaemia in dogs. 81 
 82 
Material and methods 83 
Inclusion criteria 84 
The FC database of the Department of Veterinary Medicine, University of Milan, Italy, was 85 
searched retrospectively and canine cases were identified over a period of six years (2009-2015). 86 
Inclusion criteria were: (1) LN FNA sent for flow cytometric immunophenotyping; and (2) presence 87 
of a final FC report in the database. If other sample types, such as peripheral blood (PB), bone 88 
marrow (BM) aspirates, body cavity effusions, FNA from mass lesions, spleen, liver or other 89 
tissues, were submitted, these cases were included in the present caseload only if a LN FNA from 90 
the same patient was analysed, regardless of the diagnostic pathway used and what tissue (e.g. PB 91 
or BM for leukaemias) was considered first in the diagnostic pathway. Exclusion criteria included: 92 
(1) cases composed of tissues other than LN aspirates; and (2) cases sent for minimal residual 93 
disease analysis. 94 
 95 
Sample collection 96 
Samples were collected from one or more enlarged LNs by multiple aspirations, with or 97 
without suction, using a fine needle (21-22 ga). The collected material was suspended in 1 mL of a 98 
transport medium (Roswell Park Memorial Institute, RPMI 1640, recommended; phosphate 99 
buffered saline; saline solution, not recommended), refrigerated at 4-6 °C and shipped to the 100 
laboratory within 24 h from sampling with a cold pack in the envelope to maintain sample cooling. 101 
 102 
 At admission, samples were analysed visually and cellularity was evaluated using an 103 
automated analyser (Sysmex XT-2000iV). Cellularity was generally considered to be suitable if the 104 
cell concentration in 1 mL was > 5 x 10
9 
cells/L (corresponding to > 5 x 10
6
 cells in total), whereas 105 
samples with < 1 x 10
9
 cells/L (corresponding to < 1 x 10
6
 cells in total) were generally excluded 106 
from processing, although slight variability may have occurred due to the preferences of the 107 
operator dealing with the sample. 108 
 109 
Flow cytometry 110 
Processing for FC was performed as described previously (Gelain et al., 2008). The 111 
erythrocyte lysis step was generally not considered necessary for LN FNA samples unless gross 112 
haemodilution was detected at visual inspection. For PB and BM samples, red blood cells were 113 
lysed by adding a lysis solution containing 8% ammonium chloride. 114 
 115 
 The panel of antibodies applied to LN samples was adapted over the years due to the 116 
increased availability of conjugated antibodies against canine leukocytes. Samples processed before 117 
2011 were analysed using mainly a two-colour approach. Starting from 2011, a multicolour 118 
approach was applied with the addition of CD45 as tracking label in all tubes. The diagnostic 119 
algorithm varied throughout the years, but a basic panel included antibodies against CD5, CD21, 120 
CD34, and CD45. On the basis of the staining results obtained with this panel, expression of other 121 
antigens was evaluated, including CD3, CD4, CD8, CD11b, CD14, CD18, CD20, CD25, CD44, 122 
CD79a, CD117 and MHCII. The antibody panel used to label PB and BM samples varied based on 123 
the phenotype of neoplastic cells identified in the LN sample. If the LN sample was not adequate 124 
for FC, the basic antibody panel was applied to PB and BM, with the addition of CD4 and CD8. 125 
Specificity, sources and clones of antibodies are listed in Novacco et al. (2015). Samples were 126 
acquired using a flow cytometer (FACScalibur, Becton Dickinson) and analysed using Cell Quest 127 
software (Becton Dickinson). All FC interpretations and reports were made by one board-certified 128 
clinical pathologist (SC). 129 
 130 
 The final diagnosis was based on a comprehensive evaluation of all the data provided by the 131 
referring veterinarian, including different combinations of history, presenting complaint, clinical 132 
signs, LN cytological smear, haematology data and LN/PB/BM FC analysis. Cases included in the 133 
present study were classified based only on the FC report, without any re-evaluation of the raw FC 134 
data. 135 
 136 
Criteria for diagnosis 137 
 The final diagnosis was derived from the flow cytometry report and was based on cytology 138 
findings, if available, combined with a comprehensive interpretation of flow cytometric results 139 
obtained from LN aspirates and other sample material. Samples were considered to be ‘non-140 
diagnostic’ if one or more of the following criteria were present: (1) acellularity (<1x106 cells in 141 
total); (2) sample composed of primarily dead cells; and (3) if flow cytometric results strongly 142 
differed from cytological evaluation, for example, when neoplastic cells disrupted during 143 
processing and only a small residual non-neoplastic population was labelled). Dead cells were 144 
identified by gross evaluation of the sample (based on colour, odour or the presence of tissue 145 
debris) and/or with a viability stain (propidium iodide), which was included in the last 2 years of the 146 
study period. Samples were considered ‘negative for lymphoid tumour’ if: (1) a mixed population 147 
of predominantly small cells was present with a cytology supporting a reactive/hyperplastic lymph 148 
node; or (2) other causes of lymphadenomegaly were identified by immunophenotyping and 149 
cytology, for example, LN metastasis from solid tumours, histiocytic tumours and plasma cell 150 
tumours. Samples were considered as ‘likely lymphoid tumour’ if: (1) flow cytometry from a lymph 151 
node showed a highly prevalent population (> 65%) of lymphoid cells with a single phenotype, but 152 
only a reduced panel of antibodies was allowed and/or the lack of a good quality cytological smear 153 
precluded a definitive diagnosis; (2) flow cytometry from a lymph node was poorly cellular (< 1 x 154 
10
6
 cells in total) or provided equivocal results, but LN cytology was highly suggestive of 155 
lymphoma and immunophenotyping of PB and/or BM was suggestive of a lymphoid tumour. In 156 
these cases, a diagnosis of ‘likely lymphoid tumour’ was made. Cases were classified as ‘lymphoid 157 
tumour’ if a definitive diagnosis of lymphoma or leukaemia was made based on the results of 158 
immunophenotyping of LN, PB, or BM. In many cases, extended subtyping of lymphoid neoplasia 159 
was possible based on immunophenotyping of different tissues and cytological evaluation: (1) B 160 
cell lymphoma (irrespectively of the grade); (2) high grade T cell lymphoma (based on 161 
immunoreactivity to T cell markers and cytological aspects including high numbers of mitotic 162 
figures); (3) low grade T cell lymphoma (based on typical T zone pattern staining on FC and/or 163 
distinctive cytological features); (4) acute leukaemia (starting with PB or BM immunophenotyping 164 
of precursor cells confirmed by LN infiltration); and (5) chronic lymphocytic leukaemia (starting 165 
with PB or BM immunophenotyping confirmed by LN infiltration). 166 
 167 
Statistical analysis 168 
Statistical analysis was applied to identify pre-analytical variables possibly affecting the 169 
likelihood to reach a diagnosis; for this aim, samples were grouped into ‘diagnostic’ (if any 170 
diagnosis had been made, regardless of the level of confidence) and ‘non-diagnostic’ (including 171 
samples not adequate for processing and samples processed but not diagnostic). Pre-analytical 172 
variables investigated were related to: (1) the patient: breed (pure or mixed), age (years), sex 173 
(female, spayed female, male, neutered male), size (toy/small, medium, large/giant); (2) sampling 174 
and shipping: year (from 2009 to 2015), season (cool to cold from October to March, warm to hot 175 
from April to September), referring veterinarian (veterinarians who sent > 10 cases over the study 176 
period were considered individually, while veterinarians sending less than 10 cases in total were 177 
grouped in a single category), origin and shipping (‘within institution’, ‘out of institution hand-178 
delivered’, ‘out of institution delivered by express courier’); (3) sample: type of sample (LN alone, 179 
LN plus PB, LN plus PB and BM, LN plus BM), LN cytological smear (present or not), cellular 180 
concentration of the LN sample (x 10
9 
cells/L), presence of gross artefacts (haemodilution, dead 181 
cells, none). Univariate and multivariate binomial logistic regressions were performed using SPSS 182 
v20.0 for Windows (IBM). Multivariate analysis was performed with a backward step selection, 183 
including only variables with P ≤ 0.3 at univariate analysis. Significance was set at P ≤ 0.05. 184 
 185 
Results 186 
Out of 1273 samples, 264 cases were excluded due to lack of information regarding the 187 
sample (n = 88; 6.9%) or due to sampling of tissues other than LN (n = 176; 13.8%). Among the 188 
latter, 59 (33.5%) cases were represented by PB and BM, 49 (27.8%) cases by PB alone, 28 189 
(15.9%) cases by extranodal masses (other than cutaneous), 18 (10.2%) cases by effusions, nine 190 
(5.1%) cases by spleen, seven (4.0%) cases by cutaneous masses, two (1.1%) cases by liver, and 191 
four (2.3%) cases by other tissues. Twenty-two cases (1.73%) were excluded because the final 192 
report was not available. Finally, 987 cases fulfilled the inclusion criteria and were included in the 193 
statistical analysis. 194 
 195 
 Seventy-two (7.3%) samples were non-diagnostic. Among the 915 diagnostic FNAs, 839 196 
(91.7%) were ‘conclusive for lymphoid tumour’, 61 (6.7%) were ‘negative for lymphoid tumour’, 197 
and 15 (1.6%) were ‘likely lymphoid tumour’. A specific diagnosis was available for 812 cases; 596 198 
(73.4%) cases were B cell lymphomas, 143 (17.6%) cases were high grade T cell lymphomas, 60 199 
(7.4%) cases were low grade T cell lymphomas, 8 (1.0%) cases were acute leukaemias, and five 200 
(0.6%) cases were chronic lymphocytic leukaemias. The results of univariate and multivariate 201 
analyses and the odd ratios for diagnostic samples are summarised in Table 1. 202 
 203 
Patient-related variables 204 
Breed was reported in 911 cases; there were 239 (26.2%) mixed breed dogs. Among the 205 
remaining 672 dogs, the most prevalent breeds included German shepherd (n = 59; 8.8%), Boxer (n 206 
= 56; 8.3%), Golden retriever (n = 46; 6.8%), Labrador retriever (n = 44; 6.5%), Rottweiler (n = 38; 207 
5.7%) Doberman pinscher (n = 37; 5.5%), Beagle (n = 29; 4.3%), Bernese mountain dog (n = 23; 208 
3.4%), English bulldog (n = 21; 3.1%) and Yorkshire terrier (n = 21; 3.1%). Many other breeds 209 
were represented, with less than 20 cases each. In 76 cases, the breed was not recorded. Since the 210 
size of mixed breed dogs was generally not available, this variable was analysed only within the 211 
pure-breed dog group. Among the latter, the majority of cases were of large/giant size (n = 415; 212 
61.8%); 142 (21.1%) dogs were of toy/small size, and 115 (17.1%) were medium-sized. Sex was 213 
reported in 901 cases: there were 213 (23.6%) females, 210 (23.3%) spayed females, 397 (44.1%) 214 
males and 81 (9.0%) neutered males. The male/female ratio was 1.15:1. Age was known for 899 215 
dogs. Median age was 8 years (mean 8.4 ± 3.2 years, range 1-17 years). None of the patient-related 216 
variables significantly influenced the likelihood of having a diagnostic sample. 217 
 218 
Variables related to sampling and shipping 219 
The number of cases per year steadily increased during the study period, ranging from 63 220 
cases fulfilling the inclusion criteria in 2009 to 200 cases in 2015. The highest percentage of 221 
diagnostic cases was reached in 2012 (124/128 cases, 96.9%) and the lowest in 2015 (174/200 222 
cases, 87.0%). The likelihood of having a diagnostic sample significantly varied by years both with 223 
univariate and multivariate analysis (P = 0.031 and P = 0.016, respectively). 224 
 225 
 The percentage of samples collected in the cold and hot seasons was almost similar (51.2% 226 
and 48.8%, respectively) without any significant difference (P=0,154).  227 
Thirteen veterinarians sent >10 samples, ranging from 13 to 207 samples; veterinarians sending < 228 
10 samples were grouped all together, to a final count of 363 (36.8%) cases. Most of the samples 229 
for which this information was available had been sent to the laboratory by express courier 230 
(559/816, 68.5%), 159 (19.5%) were sampled outside the institution and hand-delivered, and 98 231 
(9.9%) were sampled within the institution. The likelihood of a having a diagnostic sample was not 232 
influenced by these variables with univariate analysis. However, the proportion of diagnostic 233 
samples significantly varied among veterinarians based on multivariate analysis (P = 0.004). 234 
 235 
Variables related to sample material 236 
In the majority of cases (572; 58.0%), samples from all three sites (LN, PB and BM) of the 237 
same dog were available; LN and PB were sent in 225 (22.8%) cases, LN alone was submitted in 238 
163 (16.5%) cases, and LN and BM were sent to the laboratory in 27 (2.7%) cases. Sample material 239 
significantly influenced the likelihood of obtaining a diagnosis (P = 0.025). In particular, cases for 240 
which both LN and PB or all three sites (LN, PB and BM) were obtained had a higher likelihood of 241 
being diagnostic, compared to samples from LN alone (P = 0.011 and P = 0.006, respectively). The 242 
type of sample material also significantly influenced the likelihood of having diagnostic samples at 243 
multivariate analysis (P = 0.031). 244 
 245 
 A LN cytological smear was provided in 634/987 (64.2%) cases, but the quality of these 246 
smears was not assessed in the present study. The presence of a cytological smear significantly 247 
improved the likelihood of having a diagnostic sample (P = 0.009) only at univariate analysis. 248 
Lymph node sample cellularity was highly variable among cases, ranging from 0.02 to 436.19 x 10
9
 249 
cells/L (median 12.44 x 10
9
 cells/L, mean 29.21±48.13 x 10
9
 cells/L). Lymph node sample 250 
cellularity did not affect the likelihood of having diagnostic samples based on univariate analysis 251 
(P=0.104) , but was statistically significant at multivariate analysis (P=0.013), with cellularity being 252 
higher in diagnostic than in non-diagnostic samples (median 13.1 x 10
9
 cells/L and 2.09 x 10
9
 253 
cells/L, respectively). In the group of non-diagnostic cases, the cellularity was lower than the 254 
minimum adequate concentration (5.0 x 10
9
/L) in 52.8% of cases, and lower than the lower cut-off 255 
value generally considered to be suitable for analysis (1.0 x 10
9
/L) in 37.5% of cases. These 256 
percentages were much higher than those found in diagnostic samples (21.0% and 3.4%, 257 
respectively). 258 
 259 
 Artefacts were reported in nine non-diagnostic samples (12.5%), including one 260 
haemodiluted sample and eight necrotic samples, and in 18 diagnostic samples (2.0%), including 261 
three haemodiluted and 15 necrotic samples. Haemodilution did not affect the likelihood of having 262 
a diagnostic sample. On the contrary, necrotic samples were significantly less likely to be diagnostic 263 
in both univariate and multivariate analysis (P < 0.001 for both analyses). 264 
 265 
Discussion 266 
The results of the present study indicate that FC is suitable to refine a tentative diagnosis of 267 
canine lymphoma because it provided diagnostic results in the majority of cases (about 90%). 268 
Among the pre-analytical variables investigated, no association was identified between signalment 269 
and the likelihood to obtain a diagnostic result. In particular, neither dog size nor breed (often 270 
related to breed specific temperament) influenced the odds of obtaining a diagnosis. Fine needle 271 
aspiration of a lymph node is usually carried out without sedation, and, in theory, obtaining a good 272 
quality fine needle aspirate is more difficult in small-sized or aggressive dogs. On the other hand, 273 
the sampling of superficial lymph nodes may be more difficult in breeds in which the subcutaneous 274 
tissue is abundant. However, the results of the present study indicate that FNA provides good 275 
quality samples in the great majority of cases regardless of the animal’s signalment. 276 
 277 
In contrast, the likelihood of obtaining a diagnosis varied among submitting 278 
veterinarians/institutions, possibly reflecting different technical skills of the operator (veterinarian) 279 
who performs the sampling. These data support the necessity of an adequate technical training in 280 
order to increase the likelihood of having a diagnostic result. 281 
 282 
Delivery method did not influence the diagnostic utility. No differences were found among 283 
samples submitted from the internal oncology service of the University of Milan, which were 284 
delivered within few minutes following sampling, those delivered in person within a few hours 285 
following sample collection, and those shipped using an express courier. 286 
 287 
Likewise, no differences were found between samples shipped during the cold and hot 288 
seasons. Of notice, the standard requirements of our laboratory include a maximum shipping time of 289 
24 h and shipment on ice packs for FC samples. Therefore, our results are only valid under these 290 
conditions. In human medicine, refrigeration of FC samples generally is not recommended, since 291 
some antigens may be internalised and bias the final results (Ekong et al., 1993). Studies on this 292 
aspect in veterinary medicine are currently lacking, but it seems reasonable to refrigerate the 293 
samples during shipment to prevent cell disruption due to high temperature, mainly in hot seasons 294 
and in hot countries. It is currently unknown whether canine antigens vary their expression 295 
following refrigeration. 296 
 297 
Sample type and sample characteristics had the greatest influence on the diagnostic power of 298 
flow cytometry. The major factor leading to a non-diagnostic result was poor cellularity, with more 299 
than a half of non-diagnostic samples having a cell concentration lower than recommended. 300 
Artefacts such as haemodilution and dead cells showed a minor effect on non-diagnostic samples. 301 
Haemodilution was rarely related to a non-diagnostic sample because a rapid lysis step was added 302 
to the procedure when gross haemodilution was evident. The presence of many non-viable cells is 303 
uncommon in LN FNAs, at least in untreated dogs. When present, the necrotic debris may be easily 304 
identified by gross evaluation (based on colour, odour or the presence of tissue debris) or using a 305 
viability stain, such as propidium iodide. The latter procedure was included in the last 2 years of the 306 
study period but it is not possible to determine if this inclusion could have influenced the percentage 307 
of diagnostic results. 308 
 309 
 Having sample material from different sites (LN, PB, BM) and a concurrent LN cytological 310 
smear available improved the likelihood of establishing a diagnosis of lymphoid neoplasia. 311 
Therefore, complete cases, including FNA from a LN, PB, BM and cytology smears, are desirable 312 
for a more comprehensive evaluation by a clinical pathologist. Specifically, cytological evaluation 313 
of a smear may help to differentiate reactive/hyperplastic lymph nodes from lymphoid tumours in 314 
which the neoplastic population, which tends to be more fragile, has been disrupted. In the first 315 
case, samples would be classified as ‘diagnostic, non-neoplastic’, while in the second case they 316 
would be classified as ‘non-diagnostic’. When a fresh cytological smear was not included, a 317 
cytospin or a cytology of the sediment from the cell suspension submitted for FC was generally 318 
prepared to better interpret FC results. However, these smears were often of poor quality for an 319 
adequate cytological evaluation and they were only used to confirm the FC results. 320 
 321 
 The presence of neoplastic cells detected via flow cytometry in PB and/or BM, together with 322 
a LN cytology compatible with lymphoma, may also permit a putative diagnosis of ‘likely 323 
lymphoma’, even if LN sample cellularity is too low for FC. This could be achieved when 324 
neoplastic cells can be differentiated from non-neoplastic cells, for example when the cells showed 325 
an aberrant phenotype (such as a T zone pattern) or when a high percentage of large CD21 positive 326 
cells were detected. Although it cannot be presumed that the cells in peripheral blood represented 327 
the same neoplastic population than the cells in lymph node, we considered it very likely that they 328 
were of similar origin when a cytological smear of lymph node was suggestive of lymphoma. In 329 
such cases , we used a comprehensive approach and considered all available clinical and laboratory 330 
information to make a diagnosis of  ‘likely lymphoma’. Although this assumption should be taken 331 
with care, we think that the stepwise approach of including FC of PB and/or BM when the LN 332 
sample is not suitable could be of some clinical benefit in managing dogs with lymphoma. The 333 
evaluation of PB and/or BM would also be crucial to differentiate acute and chronic lymphoid 334 
leukaemias with secondary lymph node infiltration from nodal lymphoma with a haematogenous 335 
phase. The results of our study suggest that, when LN cellularity was too low to perform FC, flow 336 
cytometry of PB was most likely to be diagnostic in case it was infiltrated. This suggests that 337 
submitting peripheral blood together with a LN aspirate will facilitate interpretation of FC results 338 
and it will also assist with staging of lymphoma. In the present study, PB and BM samples were 339 
frequently submitted to our laboratory in addition to a LN sample, mainly for staging purposes. Our 340 
results indicate that having a BM aspirate available for FC did not increase the likelihood of having 341 
a diagnostic sample if LN and PB were also submitted. 342 
 343 
 The purpose of this study was not to assess the diagnostic accuracy of FC in identifying 344 
different lymphoma subtypes. However, the frequency of lymphoma subtypes reported here is 345 
similar to frequencies reported in the literature (Ponce et al., 2010; Valli et al., 2011). This finding 346 
suggests that FC may be useful to identify different subtypes in dogs with lymphoma. This may be 347 
attributable to the high prevalence of diffuse lymphomas in dogs (Fournel-Fleury et al., 1994, 348 
Comazzi and Gelain, 2011).  349 
 350 
The limits of this study are inherent to its retrospective nature. Some possible sources of 351 
biases were not analysed, including the localisation and size of the LN sampled, the technique used 352 
for sampling (free hand vs. ultra-sound guided, suction vs. capillary technique), the use of different 353 
transport media (RPMI vs. phosphate buffer saline vs. saline solution), and the quality of the 354 
cytological smears. Another limitation is the lack of a gold standard for the final diagnosis, which 355 
precluded us from defining the diagnostic performances of both cytology and FC. This should be 356 
addressed in a future, prospective study. 357 
 358 
Conclusions 359 
Flow cytometry performed from canine LN FNA samples is a suitable diagnostic tool to 360 
confirm lymphoma in the majority of cases, regardless of patient characteristics, provided that the 361 
sample has sufficiently high cellularity, is submitted within 24 h following sampling and is shipped 362 
on ice packs. Packaging and shipping should be standardised to assure fast delivery within 24 h of 363 
sampling. Haemodilution has minimal effect on FC analysis, but veterinarians should make any 364 
possible effort to obtain a highly cellular sample. The centres of large, neoplastic nodes should be 365 
avoided if possible, they may provide more necrotic/dead cells. The addition of a PB sample and a 366 
LN cytological smear can be recommended to improve the likelihood of receiving a conclusive 367 
result. 368 
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Table 1 431 
Results of univariate and multivariate analysis for different pre-analytical variables examined for their effect on flow 432 
cytometric analysis of samples from dogs with clinically suspected lymphoma. 433 
 434 
Pre-analytical variable 
Univariate analysis Multivariate analysis 
Odds ratio 95% confidence interval P value P value 
Related to animal Breed 0.999 0.597-1.670 0.996 ND 
Age 1.035 0.959-1.117 0.378 ND 
Sex Neutered male Ref - 0.330 ND 
Male 2.672 0.803-8.888 
Female 2.112 0.599-7.450 
Spayed female 1.857 0.519-6.641 
Size Toy/Small Ref - 0.609 ND 
Medium 1.032 0.429-2.482 
Large/giant 0.754 0.371-1.531 
Related to operator Year 2009 Ref - 0.031 * 0.026 * 
2010 0.681 0.174-2.664 
2011 0.907 0.227-3.631 
2012 1.550 0.336-7.146 
2013 0.562 0.153-2.066 
2014 0.775 0.212-2.839 
2015 0.335 0.098-1.145 
Season Cold Ref - 0.154 0.130 
Hot 0.703 0.433-1.142 
Veterinarian   0.067 0.020 * 
Origin/shipping method Express courier Ref - 0.247 0.590 
Hand-delivered 0.714 0.353-1.446 
Within institution 0.453 0.160-1.286 
Related to sample  Sample material LN alone Ref - 0.025 * 0.049 * 
LN and PB 2.877 1.346-6.150 
LN, PB and BM 2.078 1.182-3.653 
LN and BM 1.849 0.408-8.380 
LN cytological smear  No Ref - 0.009 * 0.313 
Yes 1.904 1.176-3.083 
Dead cells No Ref - < 0.001 * < 0.001 * 
Yes 0.133 0.054-0.326 
Haemodilution No Ref - 0.210 ND 
Yes 0.234 0.024-2.274 
LN sample cellularity   1.008 0.998-1.017 0.104 0.013 * 
 435 
LN, lymph node; PB, peripheral blood; BM, bone marrow; Ref, reference; ND, not detectable. 436 
Odds ratio for the probability to provide a diagnostic result are also given. 437 
* P ≤ 0.05 438 Formattato: Tipo di carattere: +Corpo
(Calibri), 9 pt, Colore carattere: Testo
1, Italiano (Italia)
